Related Experiment Video
Updated: Sep 20, 2026

Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
Dose-response relationship and reproducibility of urinary salbutamol excretion during the first 30 min after an
H S Tomlinson1, S A Corlett, H Chrystyn
1School of Pharmacy, University of Bradford, Bradford, BD7 1DP.
Aims:
To determine the reproducibility and dose-response relationship for urinary salbutamol excretion post inhalation.
Methods:
Fifteen volunteers inhaled either one, two, three, four or five doses of 100 micro g salbutamol on separate days and then seven of these also repeated each of the one, three and five doses on five occasions. After each study dose urine was collected 30 min post inhalation.
Results:
The mean (SD) 30 min urinary salbutamol after one, two, three, four and five doses was 2.61 (1.0.), 5.47 (1.59), 8.68 (2.73), 12.34 (3.96) and 15.99 (4.50) micro g, respectively. Statistical analysis revealed a linear relationship (P < 0.001). Mean (SD) coefficient of variation after one, three and five doses was 10.5 (3.6), 10.1 (2.7) and 9.4 (2.3)%.
Conclusions:
The 30 min salbutamol urinary excretion post inhalation pharmacokinetic method, to compare inhaled products, is linear with inhaled dose and reproducible.
Related Concept Videos
Dose-Response Relationship: Selectivity and Specificity
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
One-Compartment Open Model: Urinary Excretion Data and Determination of k
Dose-Response Relationship: Overview
Measurement of Bioavailability: Pharmacokinetic Methods
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
